- Home
- FOR vs EMBC Comparison
FOR vs EMBC Comparison
Compare FOR & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOR
- EMBC
- Stock Information
- Founded
- FOR 2005
- EMBC 1924
- Country
- FOR United States
- EMBC United States
- Employees
- FOR N/A
- EMBC N/A
- Industry
- FOR Real Estate
- EMBC Medical/Dental Instruments
- Sector
- FOR Finance
- EMBC Health Care
- Exchange
- FOR Nasdaq
- EMBC Nasdaq
- Market Cap
- FOR 1.2B
- EMBC 1.0B
- IPO Year
- FOR 2007
- EMBC N/A
- Fundamental
- Price
- FOR $22.79
- EMBC $14.10
- Analyst Decision
- FOR Strong Buy
- EMBC Buy
- Analyst Count
- FOR 3
- EMBC 2
- Target Price
- FOR $34.00
- EMBC $19.00
- AVG Volume (30 Days)
- FOR 191.7K
- EMBC 441.4K
- Earning Date
- FOR 04-17-2025
- EMBC 02-06-2025
- Dividend Yield
- FOR N/A
- EMBC 4.25%
- EPS Growth
- FOR N/A
- EMBC 2.96
- EPS
- FOR 3.56
- EMBC 0.99
- Revenue
- FOR $1,453,900,000.00
- EMBC $1,107,700,000.00
- Revenue This Year
- FOR $10.37
- EMBC $0.26
- Revenue Next Year
- FOR $11.16
- EMBC $1.24
- P/E Ratio
- FOR $6.40
- EMBC $14.24
- Revenue Growth
- FOR N/A
- EMBC N/A
- 52 Week Low
- FOR $22.42
- EMBC $9.93
- 52 Week High
- FOR $40.92
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- FOR 39.28
- EMBC 22.61
- Support Level
- FOR $22.42
- EMBC $14.55
- Resistance Level
- FOR $23.90
- EMBC $15.72
- Average True Range (ATR)
- FOR 0.56
- EMBC 0.91
- MACD
- FOR 0.11
- EMBC -0.33
- Stochastic Oscillator
- FOR 25.00
- EMBC 6.28
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.